Meeting of the National Vaccine Advisory Committee, 52532-52533 [2010-21263]
Download as PDF
<![CDATA[
52532
Federal Register / Vol. 75, No. 165 / Thursday, August 26, 2010 / Notices
ARRA ADJUSTMENTS TO FMAP Q3 FY10—Continued
Hold harmless
FY10
State
Indiana .........................................
Iowa ..............................................
Kansas .........................................
Kentucky ......................................
Louisiana ......................................
Maine ...........................................
Maryland ......................................
Massachusetts .............................
Michigan .......................................
Minnesota .....................................
Mississippi ....................................
Missouri ........................................
Montana .......................................
Nebraska ......................................
Nevada .........................................
New Hampshire ...........................
New Jersey ..................................
New Mexico .................................
New York .....................................
North Carolina ..............................
North Dakota ................................
Ohio ..............................................
Oklahoma .....................................
Oregon .........................................
Pennsylvania ................................
Rhode Island ................................
South Carolina .............................
South Dakota ...............................
Tennessee ...................................
Texas ...........................................
Utah ..............................................
Vermont ........................................
Virginia .........................................
Washington ..................................
West Virginia ................................
Wisconsin .....................................
Wyoming ......................................
65.93
63.51
60.38
70.96
72.47
64.99
50.00
50.00
63.19
50.00
76.29
64.51
68.53
60.56
52.64
50.00
50.00
71.35
50.00
65.13
63.75
63.42
67.10
62.74
54.81
52.63
70.32
62.72
65.57
60.56
71.68
59.45
50.00
51.52
74.25
60.21
50.00
[FR Doc. 2010–21235 Filed 8–25–10; 8:45 am]
BILLING CODE 4150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Vaccine
Advisory Committee
Office of Public Health and
Science, Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice of meeting.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that the National Vaccine Advisory
Committee (NVAC) will hold a meeting.
The meeting is open to the public. Preregistration is required for both public
attendance and comment. Individuals
who wish to attend the meeting and/or
participate in the public comment
mstockstill on DSKH9S0YB1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
20:12 Aug 25, 2010
Jkt 220001
Hold harmless
FY10 FMAP
with 6.2% pt
increase
3rd Quarter
FY10
unemployment
tier
3rd Quarter
FY10
unemployment
adjustment
3rd Quarter
FY10 FMAP
unemployment
adjustment
3rd Quarter
FY10 FMAP
unemployment
hold harmless
11.5
8.5
8.5
11.5
11.5
11.5
11.5
11.5
11.5
8.5
11.5
11.5
11.5
5.5
11.5
11.5
11.5
11.5
11.5
11.5
0
11.5
11.5
11.5
11.5
11.5
11.5
5.5
11.5
11.5
11.5
8.5
11.5
11.5
11.5
11.5
11.5
3.56
2.84
3.10
2.98
2.81
3.67
5.39
5.39
3.88
3.99
2.37
3.72
3.26
2.00
5.09
5.39
5.39
2.94
5.39
3.65
0.00
3.85
3.43
3.93
4.84
5.09
3.06
1.88
3.60
4.18
2.90
3.18
5.39
5.22
2.60
4.22
5.39
75.69
72.55
69.68
80.14
81.48
74.86
61.59
61.59
73.27
60.19
84.86
74.43
77.99
68.76
63.93
61.59
61.59
80.49
61.59
74.98
69.95
73.47
76.73
72.87
65.85
63.92
79.58
70.80
75.37
70.94
80.78
68.83
61.59
62.94
83.05
70.63
61.59
75.69
72.55
69.68
80.14
81.48
74.86
61.59
61.59
73.27
61.59
84.86
74.43
77.99
68.76
63.93
61.59
61.59
80.49
61.59
74.98
69.95
73.47
76.73
72.87
65.85
63.92
79.58
70.80
75.37
70.94
80.78
69.96
61.59
62.94
83.05
70.63
61.59
72.13
69.71
66.58
77.16
78.67
71.19
56.20
56.20
69.39
56.20
82.49
70.71
74.73
66.76
58.84
56.20
56.20
77.55
56.20
71.33
69.95
69.62
73.30
68.94
61.01
58.83
76.52
68.92
71.77
66.76
77.88
65.65
56.20
57.72
80.45
66.41
56.20
session should either e-mail
nvpo@hhs.gov or call 202–690–5566 to
register.
DATES: The meeting will be held on
September 14, 2010, from 8 a.m. to 5
p.m., and September 15, 2010 from 8
a.m. to 3 p.m.
ADDRESSES: Department of Health and
Human Services; Hubert H. Humphrey
Building, Great Hall; 200 Independence
Avenue, SW., Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT:
National Vaccine Program Office,
Department of Health and Human
Services, Room 715–H, Hubert H.
Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201.
Phone: (202) 690–5566; Fax: (202) 260–
1165; e-mail: nvpo@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to Section 2101 of the Public Health
Service Act (42 U.S.C. Section 300aa–1),
the Secretary of Health and Human
Services was mandated to establish the
National Vaccine Program to achieve
optimal prevention of human infectious
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
diseases through immunization and to
achieve optimal prevention against
adverse reactions to vaccines. The
National Vaccine Advisory Committee
was established to provide advice and
make recommendations to the Director
of the National Vaccine Program on
matters related to the Program’s
responsibilities. The Assistant Secretary
for Health serves as Director of the
National Vaccine Program.
Topics to be discussed at the meeting
include the 2010–2011 Seasonal Flu
Campaign, Hepatitis B vaccination,
Healthy People 2020, vaccine safety,
and other related issues. The meeting
agenda will be posted on the Web site:
https://www.hhs.gov/nvpo/nvac at least
one week prior to the meeting. Public
attendance at the meeting is limited to
space available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the office at the address/phone
listed above at least one week prior to
E:\FR\FM\26AUN1.SGM
26AUN1
Federal Register / Vol. 75, No. 165 / Thursday, August 26, 2010 / Notices
the meeting. Members of the public will
have the opportunity to provide
comments at the meeting. Public
comment will be limited to five minutes
per speaker. Individuals who would like
to submit written statements should
e-mail or fax their comments to the
National Vaccine Program Office at least
five business days prior to the meeting.
Those wishing to register to attend the
meeting may do so by sending an e-mail
to nvpo@hhs.gov or by calling 202–690–
5566 and providing name, e-mail
address and organization.
Dated: August 23, 2010.
Bruce Gellin,
Deputy Assistant Secretary for Health,
Director, National Vaccine Program Office.
[FR Doc. 2010–21263 Filed 8–25–10; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Public Meeting of the Presidential
Commission for the Study of
Bioethical Issues
Department of Health and
Human Services, Office of Public Health
and Science, The Presidential
Commission for the Study of Bioethical
Issues.
ACTION: Notice of meeting.
AGENCY:
The Presidential Commission
for the Study of Bioethical Issues will
conduct a meeting in September. At this
meeting, the Commission will continue
discussing the emerging science of
synthetic biology, including its potential
benefits and risks, and appropriate
ethical boundaries and principles.
DATES: The meeting will take place
Monday, September 13, 2010, from 8:50
a.m. to approximately 4:15 p.m., and
Tuesday, September 14, 2010, from 9
a.m. to approximately noon.
ADDRESSES: Monday, September 13, The
Inn at Penn, 3600 Sansom Street,
Philadelphia, PA 19104. Phone 215–
222–0200. Tuesday, September 14, The
Annenberg Public Policy Center, 202
South 36th Street, Philadelphia, PA
19104. Phone 215–898–9400.
FOR FURTHER INFORMATION CONTACT: Ms.
Diane M. Gianelli, Director of
Communications, The Presidential
Commission for the Study of Bioethical
Issues, 1425 New York Avenue, NW.,
Suite C–100, Washington, DC 20005.
Telephone: 202/233–3960. E-mail:
info@bioethics.gov. Additional
information may be obtained by viewing
the Web site: https://www.bioethics.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to the Federal Advisory Committee Act,
mstockstill on DSKH9S0YB1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
20:12 Aug 25, 2010
Jkt 220001
Public Law 92–463, 5 U.S.C. App.,
notice is hereby given that the
Presidential Commission for the Study
of Bioethical Issues (PCSBI) will be
conducting a meeting. The meeting will
be held from 8:50 a.m. to approximately
4:15 p.m. on Monday, September 13,
2010, at the Inn at Penn, 3600 Sansom
Street, Philadelphia, PA 19104, and
from 9 a.m. to approximately noon on
Tuesday, September 14, 2010, at The
Annenberg Public Policy Center, 202
South 36th Street, Philadelphia, PA
19104. The meeting will be open to the
public with attendance limited to space
available. The meeting will also be Web
cast.
Under authority of Executive Order
13521, dated November 24, 2009, the
President established the PCSBI to serve
as a public forum and advise him on
bioethical issues generated by novel and
emerging research in biomedicine and
related areas of science and technology.
The Commission is charged to identify
and promote policies and practices that
assure ethically responsible conduct of
scientific research, healthcare delivery,
and technological innovation. In
undertaking these duties, the
Commission will examine specific
bioethical, legal, and social issues
related to potential scientific and
technological advances; examine
diverse perspectives and possibilities
for useful international collaboration on
these issues, and recommend legal,
regulatory, or policy actions as
appropriate. The main agenda items for
this meeting involve further discussion
of the opportunities and benefits to the
public of the emerging science of
synthetic biology, the challenges and
risks, and the ethical boundaries that
may be important to formulation of
public policy with regard to this
advancing science. The Commission
also will hear more from the perspective
of faith communities and others. The
draft meeting agenda and other
information about PCSBI, including
information about access to the Web
cast, will be available at https://
www.bioethics.gov.
The Commission welcomes input
from anyone wishing to provide public
comment on any issue before it.
Individuals who would like to provide
public comment at the meeting should
notify Ms. Diane Gianelli, Director of
Communications, by telephone at 202–
233–3960, or e-mail at
diane.gianelli@bioethics.gov. Anyone
planning to attend the meeting who
needs special assistance, such as sign
language interpretation or other
reasonable accommodations, should
also notify Ms. Gianelli in advance of
the meeting. The Commission will make
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
52533
every effort to accommodate persons
who need special assistance.
Written comments will also be
accepted in accord with the
Commission’s existing request for
public comment on the issues before the
Commission. Please address written
comments by e-mail to
info@bioethics.gov, or by mail to the
following address: Public Commentary,
The Presidential Commission for the
Study of Bioethical Issues, 1425 New
York Ave., NW., Suite C–100,
Washington, DC 20005. Comments will
be publicly available, including any
personally identifiable or confidential
business information that they contain.
Trade secrets should not be submitted.
Dated: August 17, 2010.
Valerie H. Bonham,
Executive Director, The Presidential
Commission for the Study of Bioethical Issues.
[FR Doc. 2010–21267 Filed 8–25–10; 8:45 am]
BILLING CODE 4154–06–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection:
Comment Request
In compliance with the requirement
for opportunity for public comment on
proposed data collection projects
(section 3506(c)(2)(A) of Title 44, United
States Code, as amended by the
Paperwork Reduction Act of 1995, Pub.
L. 104–13), the Health Resources and
Services Administration (HRSA)
publishes periodic summaries of
proposed projects being developed for
submission to the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and draft instruments, e-mail
paperwork@hrsa.gov or call the HRSA
Reports Clearance Officer at (301) 443–
1129.
Comments are invited on: (a) The
proposed collection of information for
the proper performance of the functions
of the agency; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology.
E:\FR\FM\26AUN1.SGM
26AUN1
]]>Agencies
[Federal Register Volume 75, Number 165 (Thursday, August 26, 2010)]
[Notices]
[Pages 52532-52533]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-21263]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Vaccine Advisory Committee
AGENCY: Office of Public Health and Science, Office of the Secretary,
Department of Health and Human Services.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that the National Vaccine Advisory Committee (NVAC) will hold a
meeting. The meeting is open to the public. Pre-registration is
required for both public attendance and comment. Individuals who wish
to attend the meeting and/or participate in the public comment session
should either e-mail nvpo@hhs.gov or call 202-690-5566 to register.
DATES: The meeting will be held on September 14, 2010, from 8 a.m. to 5
p.m., and September 15, 2010 from 8 a.m. to 3 p.m.
ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey
Building, Great Hall; 200 Independence Avenue, SW., Washington, DC
20201.
FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office,
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey
Building, 200 Independence Avenue, SW., Washington, DC 20201. Phone:
(202) 690-5566; Fax: (202) 260-1165; e-mail: nvpo@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public
Health Service Act (42 U.S.C. Section 300aa-1), the Secretary of Health
and Human Services was mandated to establish the National Vaccine
Program to achieve optimal prevention of human infectious diseases
through immunization and to achieve optimal prevention against adverse
reactions to vaccines. The National Vaccine Advisory Committee was
established to provide advice and make recommendations to the Director
of the National Vaccine Program on matters related to the Program's
responsibilities. The Assistant Secretary for Health serves as Director
of the National Vaccine Program.
Topics to be discussed at the meeting include the 2010-2011
Seasonal Flu Campaign, Hepatitis B vaccination, Healthy People 2020,
vaccine safety, and other related issues. The meeting agenda will be
posted on the Web site: https://www.hhs.gov/nvpo/nvac at least one week
prior to the meeting. Public attendance at the meeting is limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the office at the address/phone listed
above at least one week prior to
[[Page 52533]]
the meeting. Members of the public will have the opportunity to provide
comments at the meeting. Public comment will be limited to five minutes
per speaker. Individuals who would like to submit written statements
should e-mail or fax their comments to the National Vaccine Program
Office at least five business days prior to the meeting. Those wishing
to register to attend the meeting may do so by sending an e-mail to
nvpo@hhs.gov or by calling 202-690-5566 and providing name, e-mail
address and organization.
Dated: August 23, 2010.
Bruce Gellin,
Deputy Assistant Secretary for Health, Director, National Vaccine
Program Office.
[FR Doc. 2010-21263 Filed 8-25-10; 8:45 am]
BILLING CODE 4150-44-P
